De Long Mark Jeffrey Insider Trades

Insider Trading History

Track insider trading activity for De Long Mark Jeffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.38M 82,500 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $1.5M 36,606 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 36,606 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$607k 14,799 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $780k 19,006 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$780k 19,006 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$877k 21,381 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$4.7M 114,591 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $1.69M 41,250 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 41,250 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.12M 27,224 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $751k 18,303 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$751k 18,303 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$831k 18,750 shares
$44.33
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.35M 30,000 shares
$44.90
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$285k 6,952 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.27M 30,845 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.01M 24,666 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $4.7M 114,591 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.15k 368 shares
$22.15
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $4.72M 114,959 shares
Last Trade
Jan 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$792k 36,606 shares
$21.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.21M 78,353 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$73.4k 3,371 shares
$21.77
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.35M 81,724 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.4k 1,334 shares
$19.79
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Chief Business & Strat Officer
Holding Value $3.41M 83,058 shares
Last Trade
Jan 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.5k 1,780 shares
$22.19
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Senior Vice President
Holding Value $1.19M 29,054 shares
Last Trade
Oct 20, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.4k 196 shares
$58.00
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up